Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Sun Pharmaceutical Industries Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Sun Pharmaceutical Industries Ltd (SUNPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Sep 2016 Thomson Reuters Stock Report 11 $25.00

Spark Capital: Sun Pharmaceutical Industries – Company update – Rating: REDUCE; TP: 796

Sun Pharmaceutical Industries – Pricing concerns at Taro; downgrade to REDUCE Taro’s rising contribution to SUNP’s profi...

22 Sep 2016 Spark Capital Advisors(India) Private Limited 10 $92.00

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Sun Pharmaceutical Industries Limited (SUNPHARMA) - Financial and Strategic SWOT Analysis Review Summary Sun Pharmaceutical I...

20 Sep 2016 GlobalData 175 $300.00

Wright Investors Service Comprehensive Report for Sun Pharmaceuticals Industries Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

18 Sep 2016 Wright Reports 64 $75.00

MOSL: SUN PHARMA 1QFY17 (Buy)-Strong quarter led by gGleevec-Base business ramp-up is key

SUN PHARMA 1QFY17: Strong quarter led by gGleevec; Base business ramp-up is key (SUNP IN, Mkt Cap USD28.9b, CMP INR802, TP I...

16 Aug 2016 Motilal Oswal Securities Ltd. 12 $115.00

Spark Capital: 1QFY17 outlook review of Sun Pharmaceutical Industries (Rating: ADD, TP: Rs. 817)

1QFY17 outlook review of Sun Pharmaceutical Industries (Rating: ADD, TP: Rs. 817) How does our one year outlook change? ...

16 Aug 2016 Spark Capital Advisors(India) Private Limited 6 $46.00

Sun Pharmaceutical Industries Ltd_Q1FY17 Result Update

Sun Pharmaceuticals Industries’ (SUNP IN) financial performance was in-line with our expectation, led by Gleevac exclusivity ...

16 Aug 2016 IndiaNivesh Securities Pvt Ltd 6 $58.00

Sun Pharmaceuticals (SUNP) - Qtr. Update - Dated - August 12, 2016

Sun Pharma’s Q1 EBITDA was in line with our estimate led by strong US sales growth of 25% YoY (5% QoQ) driven by steady gGlee...

13 Aug 2016 Axis Capital Limited 8 $81.00

SUN.NS - Event Transcript of Sun Pharmaceutical Industries Ltd conference call, Aug. 12, 2016 / 9:00AM ET

Edited Event Transcript of SUN.NS conference call, Aug. 12, 2016 / 9:00AM ET Boston, Sep 19, 2016 (Thomson StreetEvents...

12 Aug 2016 Thomson Reuters StreetEvents 26 $75.00